Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Search Query
Submit Search
Show Search
Search Results
Submit
56,132 Results for "null"
Sort by
Relevance
Newest
Oldest
Corner Office
Ackman Got His SPARC, but Don’t Expect Him to Buy Twitter
The hedge fund manager’s persistence with the SEC finally paid off.
Michelle Celarier
October 2, 2023
Research
Here’s the First II Ranking of European Asset Managers
Norges Bank Investment Management captured the No. 1 spot on the inaugural survey, followed by Fidelity, Capital Research & Management, Wellington, and BlackRock Investment Management (UK).
Alexandra DeLuca
October 2, 2023
Premium
D.E. Shaw Settles Civil Charges With the SEC
The hedge fund giant has settled charges alleging that the firm had made it nearly impossible for employees to be whistleblowers.
Stephen Taub
October 2, 2023
Premium
Greenlight Up Sharply in September
Why David Einhorn’s hedge fund more than doubled its return in the second quarter.
Stephen Taub
October 2, 2023
Corner Office
NYU CIO Steps Down
The $5.3 billion endowment has not yet named a replacement for Kathleen Jacobs.
Alicia McElhaney
September 29, 2023
Corner Office
Why Almost Every Family Office Employee Is Getting a Fat Raise in 2023
The wealthiest families are fighting each other for a small pool of talent and driving up compensation.
Michael Thrasher
September 29, 2023
Corner Office
Funds Ebb and Flow at the Hands of Morningstar Analysts
Ratings by the research firm direct inflows and outflows for funds that total billions of dollars each year, a study found.
Michael Thrasher
September 28, 2023
Portfolio
Inside Centerbridge’s Private Credit Partnership With Wells Fargo
“Even though Wells and Centerbridge are the first, they won’t be the last,” says David Dobell, senior managing director, partnership portfolio at British Columbia Investment Management.
Alicia McElhaney
September 28, 2023
Premium
The Hedge Fund Winners From Immunovant’s Rise
The biopharma stock’s increase was a much needed boost to life sciences funds, which have made only slight gains this year.
Stephen Taub
September 28, 2023
Portfolio
The Office Isn’t Dead Yet, Says WTW
Commercial real estate still presents opportunities to invest — if you know how to play it.
Alicia McElhaney
September 27, 2023
1 of 5,614
Next
